[1] SUNG H, FERLAY J, SIEGEL R L, et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin, 2021, 71(3):209-249. [2] 郑莹,吴春晓.中国75岁以上老年人胃肠道恶性肿瘤流行状况和发展趋势[J].中华胃肠外科杂志, 2016, 19(5):481-485. [3] 彭绩,余卫业.2001-2015年深圳市肿瘤登记报告[M].北京:人民卫生出版社, 2017. [4] KIM H J, FAY M P, FEUER E J, et al.Permutation tests for joinpoint regression with applications to cancer rates[J].Statist Med, 2000, 19(3):335-351. [5] 赫捷,陈万青.2017中国肿瘤登记年报[M].北京:人民卫生出版社, 2018. [6] 许欢,李科,梁颖茹,等.2004-2016年广州市胃癌流行情况及发病趋势[J].中华肿瘤防治杂志, 2020, 27(11):835-839. [7] 程时磊,张发斌,李斌.中国人群胃癌发病影响因素meta分析[J].中国公共卫生, 2017, 33(12):1775-1780. [8] 孔丹丹,郑劼,江龙委,等.胃癌疫苗研究进展[J].中华肿瘤防治杂志, 2017, 24(19):1399-1404. [9] 袁平,郑奎城.胃癌流行病学研究进展[J].慢性病学杂志, 2018, 19(12):1671-1675, 1680. [10] BAGNARDI V, ROTA M, BOTTERI E, et al.Alcohol consumption and site-specific cancer risk:a comprehensive dose-response meta-analysis[J].Br J Cancer, 2015, 112(3):580-593. [11] 李健,马麒,任瑾,等.胃癌影响因素研究进展[J].实用肿瘤学杂志, 2020, 34(5):466-470. [12] THAPA S, FISCHBACH L A, DELONGCHAMP R, et al.Association between dietary salt intake and progression in the gastric precancerous process[J].Cancers, 2019, 11(4):467. [13] 周海滨,雷林,彭绩.深圳居民慢性病相关行为模式分析[J].中国公共卫生, 2014, 30(1):17-19. [14] 王雯雯,刘文斌,曹广文.胃癌发病性别差异的相关危险因素[J].上海预防医学, 2017, 29(4):257-260, 284. [15] 谢文瑞,吴礼浩,张敏,等.中国早期胃癌筛查流程专家共识意见在广东地区的应用[J].中华消化内镜杂志, 2020, 37(7):491-494. [16] ZENG H M, CHEN W Q, ZHENG R S, et al.Changing cancer survival in China during 2003-15:a pooled analysis of 17 population-based cancer registries[J].Lancet Glob Health, 2018, 6(5):e555-e567. [17] ALLEMANI C, MATSUDA T, DI CARLO V, et al.Global surveillance of trends in cancer survival 2000-14(CONCORD-3):analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J].Lancet, 2018, 391(10125):1023-1075. [18] 朱娟,王少明,陈茹,等.胃癌筛查现状的研究进展[J].中华肿瘤杂志, 2020, 42(7):603-608. [19] 雷林,周海滨,尚庆刚,等.2001-2016年广东省深圳市胃癌发病及趋势分析[J].中国肿瘤, 2020, 29(4):260-265. |